Department of Medicine
Thomas Hensing has not added Biography.
If you are Thomas Hensing and would like to personalize this page please email our Author Liaison for assistance.
Clinical applications of proton MR spectroscopy in oncology.
Technology in cancer research & treatment Feb, 2002 | Pubmed ID: 12614173
The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, Stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel.
Cancer Aug, 2003 | Pubmed ID: 12910523
Indications for lymphatic mapping and sentinel lymphadenectomy in patients with thin melanoma (Breslow thickness < or =1.0 mm).
Annals of surgical oncology Oct, 2004 | Pubmed ID: 15383424
Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Nov, 2004 | Pubmed ID: 15514375
Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec, 2004 | Pubmed ID: 15570087
Factors associated with the likelihood of receiving second line therapy for advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) Feb, 2005 | Pubmed ID: 15639724
A phase II trial of weekly paclitaxel and gemctiabine infused at a constant rate in patients with advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) Mar, 2005 | Pubmed ID: 15713525
Clinical evaluation and staging of patients who have lung cancer.
Hematology/oncology clinics of North America Apr, 2005 | Pubmed ID: 15833404
Duration of therapy in advanced, metastatic non-small-cell lung cancer.
Clinical advances in hematology & oncology : H&O Jan, 2003 | Pubmed ID: 16227958
Efficacy and safety of gefitinib in chemonaive patients with advanced non-small cell lung cancer treated in an Expanded Access Program.
Lung cancer (Amsterdam, Netherlands) Sep, 2006 | Pubmed ID: 16797779
Phase II study of BBR 3464 as treatment in patients with sensitive or refractory small cell lung cancer.
Anti-cancer drugs Jul, 2006 | Pubmed ID: 16917215
Combined analysis of molecular and clinical predictors of gefitinib activity in advanced non-small cell lung cancer: epidermal growth factor receptor mutations do not tell the whole story.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Jan, 2006 | Pubmed ID: 17409827
Phase I/II study of gemcitabine and exisulind as second-line therapy in patients with advanced non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Mar, 2006 | Pubmed ID: 17409860
Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysis.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Sep, 2007 | Pubmed ID: 17805063
Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based clinical practice guidelines (2nd edition).
Chest Sep, 2007 | Pubmed ID: 17873174
An innovative symptom monitoring tool for people with advanced lung cancer: a pilot demonstration.
The journal of supportive oncology Sep, 2007 | Pubmed ID: 17944147
Should health-related quality of life be measured in cancer symptom management clinical trials? Lessons learned using the functional assessment of cancer therapy.
Journal of the National Cancer Institute. Monographs , 2007 | Pubmed ID: 17951232
Relationship between symptom change, objective tumor measurements, and performance status during chemotherapy for advanced lung cancer.
Clinical lung cancer Jan, 2008 | Pubmed ID: 18282359
Prevalence of poor performance status in lung cancer patients: implications for research.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Feb, 2008 | Pubmed ID: 18303431
The feasibility of adjuvant carboplatin and docetaxel in patients with curatively resected non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Feb, 2008 | Pubmed ID: 18303435
Phase II study of pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jul, 2009 | Pubmed ID: 19433684
Nanoscale cellular changes in field carcinogenesis detected by partial wave spectroscopy.
Cancer research Jul, 2009 | Pubmed ID: 19549915
A multicenter phase II trial of carboplatin and cetuximab for treatment of advanced nonsmall cell lung cancer.
Cancer investigation Feb, 2010 | Pubmed ID: 19916742
Optical detection of buccal epithelial nanoarchitectural alterations in patients harboring lung cancer: implications for screening.
Cancer research Oct, 2010 | Pubmed ID: 20924114
Nanocytology for field carcinogenesis detection: novel paradigm for lung cancer risk stratification.
Future oncology (London, England) Jan, 2011 | Pubmed ID: 21174531
Personalized treatment of lung cancer.
Seminars in oncology Apr, 2011 | Pubmed ID: 21421117
Phase 2 trial of Linifanib (ABT-869) in patients with advanced non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Aug, 2011 | Pubmed ID: 21597387
Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database.
Journal of clinical bioinformatics Feb, 2011 | Pubmed ID: 21603121
A randomized phase II trial of first-line treatment with gemcitabine, erlotinib, or gemcitabine and erlotinib in elderly patients (age ≥70 years) with stage IIIB/IV non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Sep, 2011 | Pubmed ID: 21716146
A brief symptom index for advanced lung cancer.
Clinical lung cancer Jan, 2012 | Pubmed ID: 21729652
Effect of an electronic health record on the culture of an outpatient medical oncology practice in a four-hospital integrated health care system: 5-year experience.
Journal of oncology practice / American Society of Clinical Oncology Jul, 2011 | Pubmed ID: 22043197
Mosmi Surati1,
Matthew Robinson2,
Suvobroto Nandi2,
Leonardo Faoro2,
Carley Demchuk2,
Rajani Kanteti2,
Benjamin Ferguson1,
Tara Gangadhar2,
Thomas Hensing3,
Rifat Hasina2,
Aliya Husain4,
Mark Ferguson5,
Theodore Karrison6,
Ravi Salgia2
1Pritzker School of Medicine, University of Chicago,
2Department of Medicine, University of Chicago,
3Department of Medicine, Northshore University Health Systems,
4Department of Pathology, University of Chicago,
5Department of Surgery, University of Chicago,
6Department of Biostatistics, University of Chicago